YZK-C-22

N/A

Report date: 2022/01/10 14:07:26
NME

Base Information

Drug NameYZK-C-22
Drug Alias NameYZK-C-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate kinase inhibitors
TargetsPyruvate kinase
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNankai University
China Registration ClassN/A

Develop Information

Active CompaniesNankai University
Inactive CompaniesN/A
Active IndicationsMycoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A